Effects of COVID-19 pandemic on management of acute cholecystitis: A single tertiary center's experience

Basit Öğe Kaydı
dc.contributor.authorDerebey, Murat
dc.contributor.authorYüksek, Mahmut Arif
dc.contributor.authorKarabacak, Ufuk
dc.contributor.authorMutlu, Vahit
dc.contributor.authorMizan, Salih Raşit
dc.contributor.authorTarim, Ismail Alper
dc.contributor.authorÖzbalci, Aysu Başak
dc.date.accessioned2024-10-26T17:53:06Z
dc.date.available2024-10-26T17:53:06Z
dc.date.issued2022
dc.departmentSivas Cumhuriyet Üniversitesi
dc.description.abstractFollowing the spread of novel coronavirus (COVID-19) pandemic, surgical associations have issued their different recommendations for managing the acute cholecystitis (AC) clinic during the pandemic. We aimed to examine the effects of the COVID-19 pandemic period on our clinical approach in patients who presented to the emergency department with abdominal pain and were diagnosed with AC. Medical records of patients diagnosed with AC in the emergency room between 11 March 2020 and 10 March 2021 and in the same period of one year before the pandemic were retrospectively reviewed. Patients were divided into 2 groups as COVID-19 period (Group 1) and non-COVID period (Group 2). Demographics and clinical characteristics, treatment modalities, and outcomes of these two groups were compared. The number of patients diagnosed with AC in the emergency department decreased during the ongoing COVID-19 pandemic. When the time between the onset of the complaints and the admission to the emergency service was evaluated, no statistically significant difference was found between the groups (p>0.05). The distribution of cholecystitis type and TG18 severity grading for AC were similar in both groups (p>0.05). While percutaneous cholecystostomy (PC) is more preferred in the treatment of AC during the pandemic period and the number of delayed interval laparoscopic cholecystectomy decreased, AC management was similar in both periods with no significant statistical difference (P>0.05). In conclusion, our clinical approach and management in the treatment of AC did not differ when compared to the pre-pandemic period. © 2022 Ondokuz Mayis Universitesi. All rights reserved.
dc.identifier.doi10.52142/omujecm.39.1.33
dc.identifier.endpage168
dc.identifier.issn1309-4483
dc.identifier.issue1
dc.identifier.scopus2-s2.0-85131964443
dc.identifier.scopusqualityQ4
dc.identifier.startpage164
dc.identifier.urihttps://doi.org/10.52142/omujecm.39.1.33
dc.identifier.urihttps://hdl.handle.net/20.500.12418/26716
dc.identifier.volume39
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherOndokuz Mayis Universitesi
dc.relation.ispartofJournal of Experimental and Clinical Medicine (Turkey)
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectacute cholecystitis; clinical approach; COVID-19; treatment modality
dc.titleEffects of COVID-19 pandemic on management of acute cholecystitis: A single tertiary center's experience
dc.typeReview Article

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu